About LMORX
Patient Opportunity Trust Class R is a mutual fund structured with a flexible, value-oriented equity approach that emphasizes long-term capital growth. Managed by Patient Capital Management, the fund employs an opportunistic and contrarian investment philosophy, targeting undervalued opportunities across market cycles rather than following broader market trends. The fund is actively managed, maintaining a high active share of over 97%, which means its portfolio holdings significantly diverge from standard benchmarks like the S&P 500, offering diversification for investors seeking alternatives to traditional index exposure.
The fund typically invests in a concentrated portfolio, with around 38 holdings, and spans various sectors, focusing primarily on mid-cap value equities. It may also allocate assets to debt securities of any credit quality, including high-yield bonds, to capitalize on a wider set of opportunities. The management team, led by an experienced portfolio manager, seeks to maximize returns by identifying companies and securities with compelling long-term growth prospects. With assets totaling approximately $1.3 billion and a moderate turnover rate, the fund aims to deliver sustained value over time for long-term-oriented investors.
Fund Family Patient Capital Management
Category Mid-Cap Value
Performance Rating Below Average
Risk Rating High
Stock Exchange NASDAQ
Ticker Symbol LMORX
Share Class Class R
Index S&P 500 TR
LMORX had a total return of 22.58% in the past year, including dividends. Since the fund's
inception, the average annual return has been 27.32%.
